Geneoscopy Advances Mission to Transform Gastrointestinal Health at Digestive Disease Week 2024

Company highlights capabilities of noninvasive stool-based RNA technology platform for improving patient outcomes in IBD and CRC ST, LOUIS, MO – MAY…


Court Dismisses Exact Sciences’ ‘781 Patent Infringement Claim Against Geneoscopy

Geneoscopy Continues Path Toward Commercialization of ColoSense, Bringing New Innovations in Gastrointestinal Health to Patients in Need ST, LOUIS,…


Geneoscopy Expands Leadership Team to Support ColoSense™ Rollout and Advance Precision IBD Solution

ST, LOUIS, MO – MAY 15, 2024 – Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of…


FDA Approves ColoSense™ - Geneoscopy's Noninvasive Multi-target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test

In average-risk individuals, ColoSense demonstrated 93% sensitivity for detecting colorectal cancer (CRC) and 45% sensitivity for detecting advanced…


Geneoscopy to Present Research on Inflammatory Bowel Disease at Crohn’s & Colitis Foundation’s IBD Innovate 2024 Conference

Data shows noninvasive stool RNA technology may help providers assess therapeutic response and monitor disease activity for patients with…


Geneoscopy Forms Scientific Advisory Board to Support Advancement of Precision Immunology Diagnostics for Inflammatory Bowel Disease (IBD)

ST. LOUIS, MO – January 17, 2024 – Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of…


Geneoscopy Files Inter Partes Review Petition Challenging Exact Sciences’ Patent

Extensive prior art renders Exact Sciences’ patent relating to stool collection and processing invalid ST. LOUIS, Mo. – (BUSINESS WIRE)…


Geneoscopy and Adiso Therapeutics Announce Strategic Collaboration to Investigate New Therapeutic Options for Patients with Inflammatory Bowel Disease

                                                        Adiso to Utilize Noninvasive RNA Technology Developed by Geneoscopy as a Precision Immunology…


Geneoscopy Signs Multi-Year Agreement with Labcorp to Distribute Noninvasive Multi-Target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test

Collaboration expected to increase provider and patient access to potentially life-saving colorectal cancer screening that enables earlier disease…